Lifestyle changes may reverse development of the insulin resistance syndrome - The Oslo Diet and Exercise Study: A randomized trial

被引:147
作者
Torjesen, PA
Birkeland, KI
Anderssen, SA
Hjermann, I
Holme, I
Urdal, P
机构
[1] NORWEGIAN UNIV SPORT & PHYS EDUC,DEPT BIOL & SPORTS MED,N-1087 OSLO,NORWAY
[2] ULLEVAL UNIV HOSP,DEPT CLIN CHEM,OSLO,NORWAY
关键词
D O I
10.2337/diacare.20.1.26
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To compare and assess the single and joint effect of diet and exercise intervention for 1 year on insulin resistance and the development leading toward the insulin resistance syndrome. RESEARCH DESIGN AND METHODS - An unmasked, randomized 2 x 2 factorial intervention trial was applied with a duration of 1 year for each participant. The trial comprised 219 men and women with diastolic blood pressure of 86-99 mmHg, HDL cholesterol < 1.20 mmol/l, triglycerides > 1.4 mmol/l, total cholesterol of 5.20-7.74 mmol/l, and BMI > 24 kg/m(2). Participants were randomly allocated to diet group (n=55), diet and exercise group (n=67), exercise group (n=54), and control group (n=43). The diet included increased intake of fish and reduced total fat intake. The exercise program entailed supervised endurance exercise three times a week. Baseline cross-sectional changes and 1-year changes in insulin resistance, fasting serum levels of insulin, C-peptide, proinsulin, glucose, and lipids as well as weight, mean blood pressure, and plasminogen activator inhibitor 1 (PAI-1) values were recorded. RESULTS - The cross-sectional results at baseline showed significant correlations between the calculated insulin resistance and BMI (r=0.54) and correlations between the mean blood pressure (mBP) (r=0.26) and PAI-1 (r=0.40). The 1-year diet intervention gave a significant decrease in the calculated insulin resistance from 4.6 to 4.2 and a positive correlation between the changes in insulin resistance and changes in BMI (r=0.40). The diet and exercise intervention also led to significantly decreased insulin resistance (from 5.0 to 4.0). The exercise intervention did not significantly change insulin resistance. CONCLUSIONS - The cross-sectional and 1-year intervention results supported each other and underscored the important connection between increased BMI and the development leading toward the insulin resistance syndrome.
引用
收藏
页码:26 / 31
页数:6
相关论文
共 17 条
  • [1] ANDERSSEN SA, 1995, NUTR METAB CARDIOVAS, V5, P189
  • [2] Improved carbohydrate metabolism after physical training and dietary intervention in individuals with the 'atherothrombogenic syndrome'. Oslo Diet and Exercise Study (ODES). A randomized trial
    Anderssen, SA
    Hjermann, I
    Urdal, P
    Torjesen, PA
    Holme, I
    [J]. JOURNAL OF INTERNAL MEDICINE, 1996, 240 (04) : 203 - 209
  • [3] ATHEROGENESIS IN DIABETES
    BIERMAN, EL
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1992, 12 (06): : 647 - 656
  • [4] HYPERPROINSULINEMIA OF TYPE-II DIABETES IS NOT PRESENT BEFORE THE DEVELOPMENT OF HYPERGLYCEMIA
    BIRKELAND, KI
    TORJESEN, PA
    ERIKSSON, J
    VAALER, S
    GROOP, L
    [J]. DIABETES CARE, 1994, 17 (11) : 1307 - 1310
  • [5] RELATIONSHIP BETWEEN DEGREE OF OBESITY AND INVIVO INSULIN ACTION IN MAN
    BOGARDUS, C
    LILLIOJA, S
    MOTT, DM
    HOLLENBECK, C
    REAVEN, G
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 248 (03): : E286 - E291
  • [6] MULTIPLE-REGRESSION ANALYSIS OF RISK-FACTORS FOR CARDIOVASCULAR-DISEASE AND CANCER MORTALITY IN BUSSELTON, WESTERN-AUSTRALIA - 13-YEAR STUDY
    CULLEN, K
    STENHOUSE, NS
    WEARNE, KL
    WELBORN, TA
    [J]. JOURNAL OF CHRONIC DISEASES, 1983, 36 (05): : 371 - 377
  • [7] INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE
    DEFRONZO, RA
    FERRANNINI, E
    [J]. DIABETES CARE, 1991, 14 (03) : 173 - 194
  • [8] DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214
  • [9] PROSPECTIVE ANALYSIS OF THE INSULIN-RESISTANCE SYNDROME (SYNDROME-X)
    HAFFNER, SM
    VALDEZ, RA
    HAZUDA, HP
    MITCHELL, BD
    MORALES, PA
    STERN, MP
    [J]. DIABETES, 1992, 41 (06) : 715 - 722
  • [10] HJERMANN I, 1992, J CARDIOVASC PHAR S8, V20, P5